Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4HBV4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 122 | 124 | PF00675 | 0.636 |
CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.470 |
CLV_PCSK_PC1ET2_1 | 105 | 107 | PF00082 | 0.510 |
CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.437 |
CLV_PCSK_SKI1_1 | 150 | 154 | PF00082 | 0.543 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.594 |
DOC_CYCLIN_RxL_1 | 182 | 194 | PF00134 | 0.520 |
DOC_CYCLIN_RxL_1 | 7 | 17 | PF00134 | 0.555 |
DOC_MAPK_gen_1 | 123 | 130 | PF00069 | 0.305 |
DOC_MAPK_gen_1 | 182 | 191 | PF00069 | 0.454 |
DOC_MAPK_gen_1 | 281 | 288 | PF00069 | 0.451 |
DOC_PP1_RVXF_1 | 148 | 155 | PF00149 | 0.273 |
DOC_PP1_RVXF_1 | 180 | 186 | PF00149 | 0.415 |
DOC_PP4_FxxP_1 | 311 | 314 | PF00568 | 0.325 |
DOC_PP4_FxxP_1 | 331 | 334 | PF00568 | 0.558 |
DOC_USP7_UBL2_3 | 14 | 18 | PF12436 | 0.534 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.684 |
DOC_WW_Pin1_4 | 42 | 47 | PF00397 | 0.669 |
LIG_Actin_WH2_2 | 196 | 212 | PF00022 | 0.433 |
LIG_Actin_WH2_2 | 89 | 107 | PF00022 | 0.484 |
LIG_BIR_III_2 | 211 | 215 | PF00653 | 0.368 |
LIG_BRCT_BRCA1_1 | 44 | 48 | PF00533 | 0.523 |
LIG_BRCT_BRCA1_2 | 44 | 50 | PF00533 | 0.524 |
LIG_EH_1 | 303 | 307 | PF12763 | 0.365 |
LIG_eIF4E_1 | 320 | 326 | PF01652 | 0.190 |
LIG_FHA_1 | 142 | 148 | PF00498 | 0.438 |
LIG_FHA_1 | 259 | 265 | PF00498 | 0.529 |
LIG_FHA_1 | 85 | 91 | PF00498 | 0.308 |
LIG_FHA_1 | 93 | 99 | PF00498 | 0.321 |
LIG_FHA_2 | 297 | 303 | PF00498 | 0.566 |
LIG_FHA_2 | 314 | 320 | PF00498 | 0.194 |
LIG_LIR_Gen_1 | 107 | 115 | PF02991 | 0.353 |
LIG_LIR_Gen_1 | 26 | 34 | PF02991 | 0.584 |
LIG_LIR_Gen_1 | 319 | 326 | PF02991 | 0.337 |
LIG_LIR_Gen_1 | 53 | 58 | PF02991 | 0.674 |
LIG_LIR_Gen_1 | 85 | 93 | PF02991 | 0.330 |
LIG_LIR_Nem_3 | 107 | 111 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 201 | 205 | PF02991 | 0.387 |
LIG_LIR_Nem_3 | 26 | 30 | PF02991 | 0.579 |
LIG_LIR_Nem_3 | 319 | 323 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 53 | 57 | PF02991 | 0.661 |
LIG_LIR_Nem_3 | 85 | 89 | PF02991 | 0.362 |
LIG_MLH1_MIPbox_1 | 44 | 48 | PF16413 | 0.523 |
LIG_Pex14_2 | 311 | 315 | PF04695 | 0.372 |
LIG_Rb_LxCxE_1 | 94 | 107 | PF01857 | 0.390 |
LIG_SH2_CRK | 54 | 58 | PF00017 | 0.689 |
LIG_SH2_CRK | 86 | 90 | PF00017 | 0.355 |
LIG_SH2_GRB2like | 112 | 115 | PF00017 | 0.355 |
LIG_SH2_NCK_1 | 115 | 119 | PF00017 | 0.418 |
LIG_SH2_PTP2 | 202 | 205 | PF00017 | 0.398 |
LIG_SH2_STAP1 | 115 | 119 | PF00017 | 0.387 |
LIG_SH2_STAP1 | 320 | 324 | PF00017 | 0.190 |
LIG_SH2_STAP1 | 54 | 58 | PF00017 | 0.655 |
LIG_SH2_STAP1 | 86 | 90 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 202 | 205 | PF00017 | 0.366 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.620 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.344 |
LIG_SH3_2 | 5 | 10 | PF14604 | 0.514 |
LIG_SH3_3 | 2 | 8 | PF00018 | 0.643 |
LIG_SUMO_SIM_par_1 | 87 | 95 | PF11976 | 0.306 |
LIG_TRAF2_1 | 204 | 207 | PF00917 | 0.249 |
LIG_UBA3_1 | 12 | 19 | PF00899 | 0.585 |
MOD_CDC14_SPxK_1 | 7 | 10 | PF00782 | 0.612 |
MOD_CDK_SPxK_1 | 4 | 10 | PF00069 | 0.623 |
MOD_CK1_1 | 238 | 244 | PF00069 | 0.386 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.660 |
MOD_CK2_1 | 296 | 302 | PF00069 | 0.375 |
MOD_CK2_1 | 313 | 319 | PF00069 | 0.284 |
MOD_GlcNHglycan | 240 | 243 | PF01048 | 0.364 |
MOD_GSK3_1 | 141 | 148 | PF00069 | 0.406 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.383 |
MOD_NEK2_1 | 185 | 190 | PF00069 | 0.339 |
MOD_NEK2_1 | 191 | 196 | PF00069 | 0.328 |
MOD_NEK2_1 | 235 | 240 | PF00069 | 0.356 |
MOD_NEK2_1 | 246 | 251 | PF00069 | 0.367 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.399 |
MOD_OFUCOSY | 142 | 149 | PF10250 | 0.492 |
MOD_Plk_1 | 273 | 279 | PF00069 | 0.609 |
MOD_Plk_2-3 | 273 | 279 | PF00069 | 0.618 |
MOD_Plk_4 | 235 | 241 | PF00069 | 0.304 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.348 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.676 |
MOD_ProDKin_1 | 42 | 48 | PF00069 | 0.671 |
MOD_SUMO_for_1 | 65 | 68 | PF00179 | 0.485 |
MOD_SUMO_rev_2 | 102 | 107 | PF00179 | 0.393 |
TRG_DiLeu_BaEn_1 | 94 | 99 | PF01217 | 0.408 |
TRG_DiLeu_BaEn_3 | 68 | 74 | PF01217 | 0.445 |
TRG_ENDOCYTIC_2 | 202 | 205 | PF00928 | 0.362 |
TRG_ENDOCYTIC_2 | 320 | 323 | PF00928 | 0.432 |
TRG_ENDOCYTIC_2 | 54 | 57 | PF00928 | 0.690 |
TRG_ENDOCYTIC_2 | 86 | 89 | PF00928 | 0.355 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1II52 | Leptomonas seymouri | 58% | 98% |
A0A0S4JMI1 | Bodo saltans | 32% | 100% |
A0A1X0NXQ9 | Trypanosomatidae | 32% | 98% |
A0A3S5H798 | Leishmania donovani | 73% | 100% |
A0A422NWG5 | Trypanosoma rangeli | 36% | 100% |
D0A1C0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 98% |
E9AGW2 | Leishmania infantum | 73% | 100% |
E9AV78 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 74% | 100% |
Q4QCA2 | Leishmania major | 75% | 100% |
V5BFJ0 | Trypanosoma cruzi | 32% | 99% |